Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer’s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1568, 91-100
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT and Future Planning
This publication has 48 references indexed in Scilit:
- Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with TauopathiesJournal of Biological Chemistry, 2012
- Computational approach to structural identification of phospholipids using raw mass spectra from nanoflow liquid chromatography–electrospray ionization–tandem mass spectrometryJournal of Mass Spectrometry, 2012
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's DiseasePLOS ONE, 2012
- Identifying and validating biomarkers for Alzheimer's diseaseTrends in Biotechnology, 2011
- Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QToF-MSJournal of Lipid Research, 2010
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networksNature Neuroscience, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- CSF tau protein andβ‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek populationEuropean Journal of Neurology, 2003
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984